Phenytoin concentrations in the human brain: an in vivo microdialysis study.
We report the first human study of phenytoin concentration using in vivo microdialysis, which permits sampling the extracellular environment of the brain. This technique has been applied to patients undergoing intracranial electrode investigation for intractable epilepsy. By varying the rate of perfusion (from 2.5 to 0.25 microliters/min), it is possible to quantify the concentration of drug in the extracellular fluid (ECF), which reflects the concentration on the outer neuronal cell membrane. Samples were obtained from four catheters in two patients, in whom serum phenytoin (PHT) concentrations were held constant. Unbound serum concentrations were measured following ultrafiltration at 37 degrees C. In one patient, with left and right hippocampal probes, steady state ECF/unbound serum ratios were 87 and 84% respectively. In the second patient, with hippocampal and frontal probes, ECF/unbound serum ratios were 87 and 85% respectively. Flow rate for 50% maximal recovery averaged 1.65 microliters/min (1.5-1.7 microliters/min). We found that steady state ECF PHT concentrations corresponded closely to unbound serum concentrations. No differences are observed between different sites within the brain. Flow rates needed for equilibration of dialysate with the extracellular space were slower than reported for carbamazepine, but faster than those we found for carbamazepine-epoxide and valproate.
Scheyer
R D
RD
Department of Neurology, Yale University School of Medicine, New Haven, CT.
During
M J
MJ
Hochholzer
J M
JM
Spencer
D D
DD
Cramer
J A
JA
Mattson
R H
RH
D001921:Brain / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004569:Electroencephalography / Q000187:drug effects; D005110:Extracellular Space / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D017551:Microdialysis; D010477:Perfusion; D010672:Phenytoin / Q000097:blood / Q000493:pharmacokinetics*
D010672:Phenytoin